EP-1281: Feasibility and Toxicity analysis of doseescalation by SIB/VMAT schedule in rectal cancer patients. (May 2017) - Re, A.; Chiloiro, G.; Gambacorta, M.A.; Cellini, F.; Pesce, A.; Marchesano, D.; Mattiucci, G.C.; Manfrida, S.; Valentini, V.